Patent details

Basic Information

Publication number:

EP2580322

PCT Application Number:

US2011039789

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP117357111

PCT Publication Number:

WO2011156588

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

A MEK 1 MUTATION CONFERRING RESISTANCE TO RAF AND MEK INHIBITORS

French Title of Invention:

MUTATION DE MEK 1 CONFÉRANT UNE RÉSISTANCE AUX INHIBITEURS DE RAF ET DE MEK

German Title of Invention:

MEK-1-MUTATION FÜR RESISTENZ GEGENÜBER RAF- UND MEK-HEMMERN

SPC Number:

Dates

Filing date:

09/06/2011

Grant date:

10/01/2018

EP Publication Date:

17/04/2013

PCT Publication Date:

15/12/2011

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

10/01/2018

EP B1 Publication Date:

10/01/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

09/06/2018

Expiration date:

09/06/2031

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

03/01/2018

 

 

Name:

Dana-Farber Cancer Institute, Inc.

Address:

450 Brookline Avenue, Boston, MA 02215, United States (US)

Inventor

1

Name:

GARRAWAY, Levi, A.

Address:

United States (US)

2

Name:

WAGLE, Nikhil

Address:

United States (US)

3

Name:

EMERY, Caroline

Address:

United States (US)

Priority

Priority Number:

352959 P

Priority Date:

09/06/2010

Priority Country:

United States (US)

Classification

IPC classification:

C12N 9/12; G01N 33/574; C12Q 1/68;

Publication

European Patent Bulletin

Issue number:

201802

Publication date:

10/01/2018

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
30/10/2018	Outgoing Correspondence	1